Improved Outcomes in NOD Mice Treated with a Novel Th2 Cytokine-Biasing NKT Cell Activator
Claire Forestier(Albert Einstein College of Medicine), Steven A. Porcelli(Albert Einstein College of Medicine), Alberto Molano(Tufts University), Petr A. Illarionov(University of Birmingham), Pere Santamaría(University of Calgary), Amy R. Howell(University of Connecticut), Ian Baine(Albert Einstein College of Medicine), Toshiyuki Takaki(Okayama Saiseikai General Hospital), Elliot S. Jerud(Albert Einstein College of Medicine), Rachel M. Ndonye(University of Connecticut), Jin S. Im(Albert Einstein College of Medicine), Teresa P. DiLorenzo(Albert Einstein College of Medicine), Gurdyal S. Besra(University of Birmingham)
Cited by 85
Related Papers
Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.
|The Journal of Experimental Medicine|1993|750
Role of the Major Antigen of <i>Mycobacterium tuberculosis</i> in Cell Wall Biogenesis
|Science|1997|734
Nuclear-encoded proteins target to the plastid in <i>Toxoplasma gondii</i> and <i>Plasmodium falciparum</i>
|Proceedings of the National Academy of Sciences|1998|703
Pathway to Synthesis and Processing of Mycolic Acids in <i>Mycobacterium tuberculosis</i>
|Clinical Microbiology Reviews|2005|653
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
|Nature|1998|641